Platelets and crimson blood cells mingle in a blood clot (artificially colored).Credit score: Anne Weston, EM STP, The Francis Crick Institute/Science Picture Library
Chicago, Illinois
Overlook the gauze and bandages: electrical stimulation close to the ear would possibly assist to cut back bleeding. Researchers hope the approach may in the future be used earlier than surgical procedure, childbirth and different occasions that pose a threat of dangerously uncontrolled bleeding.
The therapy, referred to as a ‘neural tourniquet’ by its creators, helps to turbocharge the exercise of platelets, that are cell fragments that type blood clots, in keeping with preliminary outcomes introduced on the 2024 Society for Neuroscience convention.
“Anyone who’s labored within the emergency or working room is aware of how grotesque it may be to lose any person to bleeding,” Jared Huston, a trauma surgeon on the Feinstein Institutes for Medical Analysis in Manhasset, New York, who co-developed the therapy, tells Nature. “Bleeding can kill you a lot sooner than sepsis.”
Bleeding’s heavy toll
Haemorrhage, or uncontrolled bleeding, accounts for about 60,000 deaths in the USA every year1. To attempt to cut back that quantity, Huston and his colleagues are creating a therapy that targets the vagus nerves, that are giant networks of nerve fibres that hyperlink the physique with the mind. Regardless of its identify, the therapy doesn’t work like a typical tourniquet that blocks blood stream to injured appendages. As a substitute, {the electrical} pulses assist to stimulate the spleen, which shops about one-third of the physique’s platelets. The stimulation prods the spleen to prepared platelets to type a clot.
COVID vaccines and blood clots: what researchers know up to now
To check the therapy, the researchers made small cuts within the ears of wholesome pigs2. In contrast with animals that didn’t obtain the therapy, handled swine misplaced 50% much less blood, and the length of their bleeding was 40% shorter.
The workforce additionally examined the therapy on mice with haemophilia, a situation wherein the blood doesn’t clot correctly, and located comparable outcomes3. The experiment additionally hinted at how nerve stimulation achieves these outcomes: it will increase calcium uptake by platelets within the spleen and makes them extra able to launch their innards after they attain an injured blood vessel. Each actions are key to clot formation.
Final yr, Huston and Spark Biomedical, a biotechnology agency primarily based in Dallas, Texas, launched a trial of the therapy in 30 individuals. In some members, the researchers utilized delicate electrical currents to one among two stimulation websites close to the ear; management members acquired sham stimulation. The preliminary outcomes present that the therapy modestly will increase clot stability and platelet activation.
Platelets’ gradual begin
The therapy’s time scale might be an issue: platelets have been most extremely activated 2 hours after stimulation — which could make the machine impractical to be used within the emergency room. Huston remains to be analysing information about whether or not the therapy may result in extreme clotting elsewhere within the physique, however he says that nerve stimulation has been used safely for many years, giving him no motive for concern.
Thalidomide-like drug staunches bleeding from genetic illness
It’s additionally unclear whether or not elevated clot stability will translate into decreased bleeding in individuals, says Svetlana Mastitskaya, a cardiovascular neuroscientist on the College of Bristol, UK. “It might be good to see a extra seen impact of the intervention,” she says.
Huston responds that bleeding time and quantity are more durable to review in individuals than in animals, due to moral considerations about deliberately harming people. Nonetheless, it could be potential to find out the therapy’s effectiveness by learning individuals with haemophilia or who’re about to endure surgical procedure.
Researchers are additionally testing the machine in ladies with kind 1 von Willebrand illness, who usually expertise extreme menstrual bleeding and lose as a lot as a litre of blood throughout menstruation, says Spark Biomedical’s chief scientific officer, Navid Khodaparast. Members obtain one hour of stimulation twice a day in a bid to cut back their bleeding. Outcomes are forthcoming, he says.
